186 related articles for article (PubMed ID: 19661184)
1. Capecitabine-based chemoradiotherapy with adjuvant capecitabine for locally advanced squamous carcinoma of the uterine cervix: phase II results.
Domingo E; Lorvidhaya V; de Los Reyes R; Syortin T; Kamnerdsupaphon P; Lertbutsayanukul C; Vito-Cruz E; Tharavichitkul E; Jin K; Yoshihara M; Cupino N; Lertsanguansinchai P
Oncologist; 2009 Aug; 14(8):828-34. PubMed ID: 19661184
[TBL] [Abstract][Full Text] [Related]
2. Phase one dose finding study of capecitabine (Xeloda), radiotherapy and cisplatin in the treatment of locally advanced squamous cervical cancer.
Stokes Z; Symonds P; Habeshaw T; Reed N; Curto J; Joynson C; Chan S
Gynecol Oncol; 2005 Jun; 97(3):790-5. PubMed ID: 15894361
[TBL] [Abstract][Full Text] [Related]
3. Concurrent chemoradiotherapy with paclitaxel and nedaplatin followed by consolidation chemotherapy in locally advanced squamous cell carcinoma of the uterine cervix: preliminary results of a phase II study.
Zhang MQ; Liu SP; Wang XE
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):821-7. PubMed ID: 20207507
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant capecitabine combined with standard radiotherapy in patients with locally advanced rectal cancer: mature results of a phase II trial.
Dunst J; Debus J; Rudat V; Wulf J; Budach W; Hoelscher T; Reese T; Mose S; Roedel C; Zuehlke H; Hinke A
Strahlenther Onkol; 2008 Sep; 184(9):450-6. PubMed ID: 19016023
[TBL] [Abstract][Full Text] [Related]
5. Multi-institutional phase II clinical study of concurrent chemoradiotherapy for locally advanced cervical cancer in East and Southeast Asia.
Kato S; Ohno T; Thephamongkhol K; Chansilpa Y; Yuxing Y; Devi CR; Bustam AZ; Calaguas MJ; de los Reyes RH; Cho CK; Dung TA; Supriana N; Mizuno H; Nakano T; Tsujii H
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):751-7. PubMed ID: 19836154
[TBL] [Abstract][Full Text] [Related]
6. Phase II study of use of a single cycle of induction chemotherapy and concurrent chemoradiotherapy containing capecitabine/cisplatin followed by surgery for patients with resectable esophageal squamous cell carcinoma: long-term follow-up data.
Koo DH; Park SI; Kim YH; Kim JH; Jung HY; Lee GH; Choi KD; Song HJ; Song HY; Shin JH; Cho KJ; Yoon DH; Kim SB
Cancer Chemother Pharmacol; 2012 Mar; 69(3):655-63. PubMed ID: 21968953
[TBL] [Abstract][Full Text] [Related]
7. A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer.
Gatcliffe TA; Tewari KS; Shah A; Brewster WR; Burger RA; Kuo JV; Monk BJ
Gynecol Oncol; 2009 Jan; 112(1):85-9. PubMed ID: 18977518
[TBL] [Abstract][Full Text] [Related]
8. High complete response rate of concomitant chemoradiotherapy for locally advanced squamous cell carcinoma of the uterine cervix.
Lin JC; Ho ES; Jan JS; Yang CH; Liu FS
Gynecol Oncol; 1996 Apr; 61(1):101-8. PubMed ID: 8626094
[TBL] [Abstract][Full Text] [Related]
9. Phase II study of capecitabine with concomitant radiotherapy for patients with locally advanced pancreatic cancer: up-regulation of thymidine phosphorylase.
Saif MW; Black G; Roy S; Bell D; Russo S; Eloubeidi MA; Steg A; Johnson MR; Zelterman D; Diasio RB
Cancer J; 2007; 13(4):247-56. PubMed ID: 17762760
[TBL] [Abstract][Full Text] [Related]
10. Synchronous chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck using capecitabine: a single-centre, open-label, single-group phase II study.
Jegannathen A; Mais K; Sykes A; Lee L; Yap B; Birzgalis A; Homer J; Ryder WD; Slevin N
Clin Oncol (R Coll Radiol); 2011 Mar; 23(2):149-58. PubMed ID: 20951012
[TBL] [Abstract][Full Text] [Related]
11. Phase II trial of capecitabine in recurrent squamous cell carcinoma of the cervix.
Jenkins AD; Ramondetta LM; Sun C; Johnston T; Wolf JK; Bodurka DC; Brown J; Atkinson EN; Levenback C
Gynecol Oncol; 2005 Jun; 97(3):840-4. PubMed ID: 15882895
[TBL] [Abstract][Full Text] [Related]
12. Extended-field radiotherapy and high-dose-rate brachytherapy with concurrent and adjuvant cisplatin-based chemotherapy for locally advanced cervical cancer: a phase I/II study.
Chung YL; Jian JJ; Cheng SH; Hsieh CI; Tan TD; Chang HJ; Hung CF; Horng CF; Soong T; Tsou MH
Gynecol Oncol; 2005 Apr; 97(1):126-35. PubMed ID: 15790448
[TBL] [Abstract][Full Text] [Related]
13. Phase II study of capecitabine (Ro 09-1978) in patients who have failed first line treatment for locally advanced and/or metastatic cervical cancer.
Lorvidhaya V; Chitapanarux I; Phromratanapongse P; Kamnerdsupaphon P; Tharavichitkul E; Lertsanguansinchai P; Hsieh CY; Sukthomya V
Gan To Kagaku Ryoho; 2010 Jul; 37(7):1271-5. PubMed ID: 20647708
[TBL] [Abstract][Full Text] [Related]
14. Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer.
Rao GG; Rogers P; Drake RD; Nguyen P; Coleman RL
Gynecol Oncol; 2005 Jan; 96(1):168-72. PubMed ID: 15589596
[TBL] [Abstract][Full Text] [Related]
15. Phase II trial of a novel capecitabine dosing schedule in combination with lapatinib for the treatment of patients with HER2-positive metastatic breast cancer.
Gajria D; Gonzalez J; Feigin K; Patil S; Chen C; Theodoulou M; Drullinsky P; D'Andrea G; Lake D; Norton L; Hudis CA; Traina TA
Breast Cancer Res Treat; 2012 Jan; 131(1):111-6. PubMed ID: 21898114
[TBL] [Abstract][Full Text] [Related]
16. Capecitabine monotherapy for recurrent and metastatic nasopharyngeal cancer.
Chua D; Wei WI; Sham JS; Au GK
Jpn J Clin Oncol; 2008 Apr; 38(4):244-9. PubMed ID: 18407933
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and tolerability of limited field radiotherapy with concurrent capecitabine in locally advanced pancreatic cancer.
Jackson AS; Jain P; Watkins GR; Whitfield GA; Green MM; Valle J; Taylor MB; Dickinson C; Price PM; Saleem A
Clin Oncol (R Coll Radiol); 2010 Sep; 22(7):570-7. PubMed ID: 20650619
[TBL] [Abstract][Full Text] [Related]
18. Definitive chemoradiation therapy with capecitabine in locally advanced pancreatic cancer.
Kim HS; Yi SY; Jun HJ; Lee J; Park SH; Lee JK; Lee KT; Lee KH; Choi DW; Choi SH; Heo JS; Park YS; Lim HY; Kang WK; Park HC; Lim DH; Park JO
Anticancer Drugs; 2010 Jan; 21(1):107-12. PubMed ID: 19829097
[TBL] [Abstract][Full Text] [Related]
19. [Locally advanced carcinoma of the cervix uteri (stage IIB-IIIB TNM-UICC): radiotherapy combined with simultaneous daily low-dose platinum. Phase II study].
Micheletti E; La Face B; Bianchi E; Cagna E; Sartori E
Radiol Med; 1996 May; 91(5):628-34. PubMed ID: 8693131
[TBL] [Abstract][Full Text] [Related]
20. Preoperative concomitant boost intensity-modulated radiotherapy with oral capecitabine in locally advanced mid-low rectal cancer: a phase II trial.
Li JL; Ji JF; Cai Y; Li XF; Li YH; Wu H; Xu B; Dou FY; Li ZY; Bu ZD; Wu AW; Tham IW
Radiother Oncol; 2012 Jan; 102(1):4-9. PubMed ID: 21903285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]